Abbott Laboratories (ABT) Saham Harga
Abbott Laboratories Harga
Selama 19 tahun terakhir pendapatan Abbott Laboratories tumbuh 3,6% per tahun, mencapai 44,33 miliar USD. Laba per saham tumbuh 6,6% per tahun selama 19 tahun terakhir. Bagi Abbott Laboratories, margin bersih sebesar 14,7% turun dibanding 16,4% beberapa tahun lalu. Pada harga saat ini imbal hasil dividen sekitar 2,15%. Rasio pembayaran sekitar 63% dari laba. Dividen tumbuh 3,8% per tahun selama 19 tahun terakhir. Target harga konsensus 12 bulan untuk Abbott Laboratories adalah 121,00 USD, sekitar di atas harga saat ini 10,3%. Dari 33 analis, 26 merekomendasikan beli — konsensus keseluruhan Beli.
Harga saham Abbott Laboratories
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Abbott Laboratories
Pertanyaan yang sering diajukan tentang saham Abbott Laboratories
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories is primarily active in the healthcare industry.
The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.
Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.
Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.
Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.
Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.
Analis saat ini menetapkan target harga rata-rata 123,64 USD untuk saham Abbott Laboratories (median: 121,00 USD), yaitu +12,7 % terhadap harga terbaru. Konsensus didasarkan pada 33 peringkat analis.
33 analis saat ini menilai saham Abbott Laboratories: 26 merekomendasikan beli, 7 tahan, dan 0 jual. Untuk 2026, analis memperkirakan Abbott Laboratories menghasilkan pendapatan 49,99 miliar USD dan laba per saham 5,52 USD.
Dengan kurs saat ini, saham Abbott Laboratories diperdagangkan pada 98,72 EUR (109,71 USD).
Saham Abbott Laboratories (ABT) tercatat di 9 bursa, termasuk: NYSE (ABT), London (0Q15.L), SIX (Zürich) (ABT.SW), XETRA (ABL.DE), Frankfurt (ABL.F), München (ABL.MU), Düsseldorf (ABL.DU), Hamburg (ABL.HM).
Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.
Pendapatan diperkirakan dari Abbott Laboratories adalah 49,99 miliar USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Abbott Laboratories adalah 9,64 miliar USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Abbott Laboratories saat ini adalah 19,87. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Abbott Laboratories.
Rasio harga-terhadap-penjualan (PSR) Abbott Laboratories saat ini adalah 3,83. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Abbott Laboratories.
Skor Kualitas AlleAktien untuk Abbott Laboratories adalah 6/10.
ISIN dari Abbott Laboratories adalah US0028241000. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Abbott Laboratories adalah 850103. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Abbott Laboratories adalah ABT. Simbol ticker digunakan untuk memperdagangkan saham Abbott Laboratories di bursa saham.
Saham Abbott Laboratories
Kelompok Peer Abbott Laboratories
Abbott Laboratories Ticker
Abbott Laboratories FIGI
Semua metrik fundamental dan analisis mendalam Abbott Laboratories
Analisis saham kami untuk saham Abbott Laboratories mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Abbott Laboratories. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.